Phenotypic detection of clinical isolates of Haemophilus influenzae with altered penicillin-binding protein 3

A Aguirre-Quiñonero1,2, I C Pérez Del Molino3, C García de la Fuente3

  • 1Service of Microbiology, University Hospital Marqués de Valdecilla-IDIVAL, Avenida de Valdecilla s/n, 39008, Santander, Spain. amayiaguirre@gmail.com.

Insights

Mutations in the ftsI gene (PBP3) of Haemophilus influenzae correlate with aminopenicillin resistance. Current EUCAST guidelines may not reliably identify resistant strains, necessitating improved diagnostic approaches for ampicillin resistance.

Area of Science:

  • Microbiology
  • Genetics
  • Pharmacology

Background:

  • Aminopenicillin resistance in Haemophilus influenzae is a growing concern.
  • Mutations in the ftsI gene, encoding penicillin-binding protein 3 (PBP3), are a primary mechanism of resistance.
  • Accurate susceptibility testing is crucial for effective treatment of H. influenzae infections.

Purpose of the Study:

  • To investigate the correlation between ftsI gene mutations and aminopenicillin resistance in H. influenzae.
  • To evaluate the performance of current European Committee for Antibiotic Susceptibility Testing (EUCAST) guidelines for categorizing ampicillin, amoxicillin, and amoxicillin-clavulanate resistance.
  • To assess the utility of benzylpenicillin screening (BP1) for detecting resistant strains.

Main Methods:

  • Genetic characterization of 91 H. influenzae isolates by sequencing the ftsI gene.
  • Phenotypic testing including screening with benzylpenicillin 1U (BP1) and determination of minimum inhibitory concentrations (MICs) for ampicillin, amoxicillin, and amoxicillin-clavulanate.
  • Interpretation of MICs according to EUCAST recommendations.

Main Results:

  • Fourteen distinct amino acid substitutions in PBP3 were identified.
  • Common substitution patterns were observed in both bla-positive and bla-negative resistant PBP3 (rPBP3) strains.
  • Benzylpenicillin screening (BP1) correctly categorized most strains, but only 29% of bla-negative rPBP3 strains had ampicillin MICs above the EUCAST resistant breakpoint.
  • Current EUCAST breakpoints for ampicillin may not reliably identify bla-negative rPBP3 strains.

Conclusions:

  • The study confirms the association between ftsI mutations and aminopenicillin resistance in H. influenzae.
  • Existing EUCAST breakpoints for ampicillin may underestimate resistance in certain H. influenzae strains with mutated PBP3.
  • Further refinement of susceptibility testing guidelines is needed for accurate clinical categorization of ampicillin resistance.

Related Concept Videos

Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
576
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.2K
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
9.0K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
674
Single-Strand DNA Binding Proteins01:03

Single-Strand DNA Binding Proteins

For successful DNA replication, the unwinding of double-stranded DNA must be accompanied by stabilization and protection of the separated single strands of the DNA. This crucial task is performed by single-strand DNA-binding (SSB) proteins. They bind to the DNA in a sequence-independent manner, which means that the nitrogenous bases of the DNA need not be present in a specific order for binding of SSB proteins to it. The binding of SSB proteins straightens single-stranded DNA (ssDNA) and makes...
16.7K